ReviewPharmaceuticals (Basel, Switzerland)2025

Broad-Spectrum RAS Inhibition in Pancreatic Ductal Adenocarcinoma: Mechanistic Advances and Therapeutic Promise.

Fawaz E Alanazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.